ArticleCancer2021

Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors.

Koji Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.